Dr. Marc J. Dauer, MD

Dr. Dauer practices at Memorial Hospital Miramar - Medical Offices in Miramar, Florida.

Dr. Dauer's NPI, 1255759601, was assigned on April 2, 2014. Dr. Dauer graduated from University of Miami, Miller School of Medicine in 2014. Dr. Dauer holds Florida license ME144906.

Dr. Dauer's primary practice is Memorial Hospital Miramar - Medical Offices, at 2900 Corporate Way, Miramar, FL 33025 in Broward County. The practice phone is (954) 265-4664.

Dr. Dauer's primary practice is Memorial Hospital Miramar - Medical Offices in Miramar, Florida. Dr. Dauer is also affiliated with Memorial Regional Hospital. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Dauer to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dauer practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Dauer's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Dauer is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Dauer's licenses on file in 2 states: Florida and New York.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, chronic skin ulcer, peripheral vascular disease, varicose veins and varicose vein treatment among the conditions Dr. Dauer treats.

CMS data shows 239 Medicare services from Dr. Dauer across 12 procedure codes in 2024, for 156 Medicare patients. Medicare paid $21,864 for them.

CMS counts 156 Medicare patients who saw Dr. Dauer in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dauer's median patient age at 69, with 47% women.

In 2024, Dr. Dauer wrote 105 Medicare Part D claims for 43 patients. 50% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $27,908 in total drug cost. In 2022, CMS named 23 claims across 1 drug.

Dr. Dauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dauer as offering telehealth. CMS counts 25 procedures of leg revascularization (restoring blood flow) by Dr. Dauer, more than 85% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Dauer, published from 2011 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Cancer Vaccines, Dendritic Cells and Cell Line, Tumor. Dr. Dauer has published most often in Cancer Immunol Immunother. Dr. Dauer's most frequent co-authors are Claudius Conrad, MD, Issam Koleilat, MD and Evan C. Lipsitz, MD.

CMS Open Payments shows 63 general payments to Dr. Dauer from 16 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 84% of the total. AtriCure, Inc. paid the most, $1,246.

Dr. Dauer graduated from University of Miami, Miller School of Medicine in 2014.

Dr. Dauer is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.